» Articles » PMID: 21973089

Quantitative Real-time PCR and the (1→3)-β-D-glucan Assay for Differentiation Between Pneumocystis Jirovecii Pneumonia and Colonization

Overview
Publisher Elsevier
Date 2011 Oct 7
PMID 21973089
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated whether quantitative PCR (qPCR) and (1 → 3)-β-d-glucan assays could be used to differentiate Pneumocystis pneumonia (PCP) from Pneumocystis jirovecii colonization in immunocompromised patients with pulmonary infiltrates. A total of 40 bronchoalveolar lavage samples and 107 induced sputum samples from 147 patients who were suspected of having PCP were obtained for PCR detection of P. jirovecii. Diagnoses of definite PCP, probable PCP, pneumonia with P. jirovecii colonization (colonization) and pneumonia without colonization (non-colonization) were made in 11, 42, 15 and 60 patients, respectively. A PCP diagnosis was undetermined in 19 patients. The copy numbers, determined using qPCR, were significantly higher in definite PCP and probable PCP patients than in colonized patients. The area under the receiver-operating characteristic curve (AUC), sensitivity and specificity for discriminating definite PCP from colonization were 0.96, 100.0% and 80.0%, respectively, at a cut-off value of 1300 copies/mL. The values for discriminating probable PCP from colonization were 0.71, 66.7% and 73.3%, respectively, at a cut-off value of 340 copies/mL. β-d-glucan levels were significantly higher in patients with both definite PCP and probable PCP than in colonized patients. The AUC, sensitivity and specificity for discriminating definite PCP were 0.91, 100.0% and 80.0%, respectively, at a cut-off value of 15.6 pg/mL. The values for discriminating probable PCP were 0.78, 76.2% and 73.3%, respectively, at a cut-off value of 6.0 pg/mL. Both qPCR and the β-d-glucan assay displayed high accuracy for discriminating colonization from definite PCP and displayed moderate accuracy for discriminating colonization from probable PCP.

Citing Articles

Diagnostic tests performance in detecting Pneumocystis jirovecii: A systematic review and meta-analysis.

Zhang L, Zheng C, Sun Y, Chen X, Wang Y, Xiang H Eur J Clin Microbiol Infect Dis. 2025; .

PMID: 39900713 DOI: 10.1007/s10096-025-05051-6.


Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis.

Brown L, Rautemaa-Richardson R, Mengoli C, Alanio A, Barnes R, Bretagne S Clin Infect Dis. 2024; 79(1):161-168.

PMID: 38860786 PMC: 11259226. DOI: 10.1093/cid/ciae239.


pneumonia in people living with HIV: a review.

McDonald E, Afshar A, Assiri B, Boyles T, Hsu J, Khuong N Clin Microbiol Rev. 2024; 37(1):e0010122.

PMID: 38235979 PMC: 10938896. DOI: 10.1128/cmr.00101-22.


Determining Colonisation from Infection Using PCR-Based Diagnostics in HIV-Negative Individuals.

Watson A, Woodford J, Britton S, Gupta R, Whiley D, McCarthy K Diagnostics (Basel). 2024; 14(1).

PMID: 38201422 PMC: 10802892. DOI: 10.3390/diagnostics14010114.


Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature.

Burzio C, Balzani E, Corcione S, Montrucchio G, Trompeo A, Brazzi L Pathogens. 2023; 12(10).

PMID: 37887781 PMC: 10610317. DOI: 10.3390/pathogens12101265.